Kestra Medical Technologies LtdKMTS
Price$27.11Intrinsic value$29.7910% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $29.79median of 2 methodsbased on filings through 31 Jul 2026
Market Price $27.11Price as of 1 Oct 2026
Margin of Safety +9.9%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 10.0%/yr (balance of the path).9.0% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 69.8%Yr 79.6%Yr 89.4%Yr 99.2%Yr 109.0%
10.0% → 9.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 118.4%Yr 127.8%Yr 137.2%Yr 146.6%Yr 156.0%Yr 165.4%Yr 174.8%Yr 184.2%Yr 193.6%Yr 203.0%
9.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 8.2%
Volatility vs market (adjusted beta)0.73

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetKestra Medical Technologies LtdKMTSHealth Care
Valuation
P/E—
P/S13.6×
P/B6.7×
EV / Revenue13.6×
EV / EBITDA—
Profitability
Gross margin52.6%
Operating margin-141.7%
Net margin-140.4%
FCF margin-115.0%
Returns
ROE-67.4%
ROA-43.1%
ROIC—
Growth
Revenue growth (YoY)78.4%
5-yr fwd EPS growth9.0%
Financial strength
Debt / Equity0.33×
Current ratio4.69×
Altman Z-Score4.2
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.